What a mess! [Software]

posted by Helmut Homepage – Vienna, Austria, 2013-01-08 20:08 (4487 d 22:01 ago) – Posting: # 9799
Views: 12,606

Dear Detlew,

❝ It is explicitly stated that way (< and not ≤) in


Hauschke, Steinijans, Pigeot

"Bioequivalence Studies in Drug Development"

❝ Wiley, Chichester, 2007, page 90


That’s what I wrote above. See also on top of page 89. The Nulls are given including the boundaries and the alternatives excluding them.

❝ ... but I have 2 other minority reports for you (proof/evidence by authority: "Well, Lieschen Mueller says it's true, so it must be." :cool:)


:-D

Westlake, W.J.

"Symmetrical Confidence Intervals for Bioequivalence Trials"

❝ Biometrics, 32, p 741-744 (1976)


❝ stating the confidence interval inclusion rule explicitly with and


Diletti et.al.

"Sample size determination for bioequivalence assessment by means of confidence intervals"

❝ Int. J. Clin. Pharm., Ther. and Tox., Vol.30, Supl. 1, p. S51-58 (192)


❝ stating the two one-sided tests explicitly as

t1=(mT-mR-ln(Θ1))/(sD*sqrt(2/n)) t(1-α,df)

❝ t2=(mT-mR-ln(Θ2))/(sD*sqrt(2/n)) -t(1-α,df)


Yep, but before (p. S52):

H0: ln µT/µR≤ln θ1 or ln µT/µR≥ln θ2 (bioinequivalence)
H1: ln θ1<ln µT/µR<ln θ2 (bioequivalence)

Drives me nuts.

What about Mr Schuirmann (1987)…

H01: µTµRθ1
H11: µTµR>θ1

and

H02: µTµRθ1
H12: µTµR<θ1

Bioequivalent if

t1=:blahblah:t1-α(ν) and t2=:blahblah:t1-α(ν)

Continuing with

“The two one-sided tests procedure turns out to be operationally identical to the procedure of declaring equivalence only if the ordinary 1-2α confidence (not 1-α) confidence interval for µTµR is completely contained in the equivalence interval [θ1, θ2].”

Completely contained?

Kem Phillips (1990)

H0: µTµR<θL or µTµR>θU
H1: θLµTµRθU

continuing with

“H0 is rejected in favor of bioequivalence if TL and -TU equal or exceed t1-α,ν […]”


And so on and so forth in many papers…

❝ Other papers state the interval inclusion rule as

I ⊂ (Θ12)


Oh yes. I use it sometimes myself as well.

❝ That time the "Theory of sets" was dealt with I have skipped school :-D.


When I was in school from one year to the next everything was given as sets. Was fashionable for a while. Didn’t bother me too much because I’ve spent many schooldays in one of the many Viennese coffee houses anyhow.

❝ This is only an incomplete selection of findings which led to my uncertainness. As stated above: Using real numbers (not rounded) it will not make much a difference how we implement it,…


Agree. In my home-brew BE software I didn’t round at all, but tested for θL ≤ 90% CI ≤ θU. Ever since I’m using commercial software I’m in limbo. I validated Phoenix/WinNonlin with data sets from the literature (and even a very small one manually). But none of them “scratched at the edge”. The manual isn’t helpful:

If the interval (CI_Lower, CI_Upper) is contained within LowerBound and UpperBound, average bioequivalence has been shown.

Contained? Meaning or ?

❝ … thus we can't empirical test it via simulations.

Not sure what you mean here. :confused:

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
23 visitors (0 registered, 23 guests [including 4 identified bots]).
Forum time: 19:09 CEST (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5